The PaceNew therapies / indications available since the last 12 months 
Ayvakit®
BY: Jasper ChanJun 8, 2021

Ayvakit®
(Avapritinib) CStone Pharm(HK)Holding Limited

 

Composition:

• Available as film-coated tablet containing 100 mg, 200 mg or 300 mg of avapritinib

 

Indication(s):

• As monotherapy for the treatment of adult patients with unresectable or metastatic gastrointestinal stromal tumours (GIST) harbouring the platelet-derived growth factor receptor alpha (PDGFRA) D842V mutation

 

Drug information including formulation, indication, administration and/or presentation updated, registered or launched in Hong Kong within one year prior to the date written is regarded as new in The Pace.

The information in The Pace is provided as a courtesy service to our readers and is intended for medical professional reference only. Please peruse the latest local prescription information prior to prescription.

You May Be Interested In
Lokelma
BY: Olive TseSep 16, 2020
Vyvanse
BY: Olive TseMar 16, 2021
Paracetamol B. Braun
BY: Olive TseSep 16, 2020
Nubeqa
BY: Olive TseMar 16, 2021